Health and Healthcare
Why Johnson & Johnson Raised Guidance After Missing Sales Estimates
Published:
Last Updated:
The company is now including the estimated impact of the Actelion acquisition in its financial guidance. As such, Johnson & Johnson increased its sales guidance for the full year 2017 from a prior range of $74.1 billion to $74.8 billion to a new range of $75.4 billion to $76.1 billion. Additionally, the company increased its adjusted earnings guidance for full year from a prior range of $6.93 to $7.08 to a new range of $7.00 to $7.15 per share.
Consensus estimates call for fiscal year 2017 EPS of $7.05 on revenues of $74.73 billion. For the second quarter, analysts are looking for EPS of $1.80 on revenues of $19.05 billion.
CEO Alex Gorsky said:
Johnson & Johnson’s first-quarter results are in line with our expectations and we are confident we will achieve the full-year financial guidance we established at the beginning of the year. The pending acquisition of Actelion demonstrates our ongoing commitment to bringing innovation to patients with significant unmet needs, and provides a unique opportunity for us to expand our portfolio with leading, differentiated in-market medicines and promising late-stage products.
Consumer sales totaled $3.2 billion in the first quarter, an increase of 1% year over year. Pharmaceutical sales totaled $8.2 billion, up 0.8%, and medical device sales rose 3% to $6.3 billion.
Shares closed at $125.72 on Monday and traded down about 2.5% early at $122.56. The stock’s 52-week range is $109.32 to $129.00. The 12-month consensus analyst price target was $129.69 before the results were announced.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
